Missing/wrong data?
Log in to edit
Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study.
scientific article published on 12 March 2018
Author/s
author: Byoung Chul Cho, Christos Chouaid, Dariusz M Kowalski, Armando Santoro, Massimo Aglietta, Keunchil Park
Work details
Publication date
March 12, 2018
-
-
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.